Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial.
about
The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapySevere non-infective systemic inflammatory response syndrome, shock, and end-organ dysfunction after zoledronic acid administration in a child.Paget's disease population analysis within Rheumatology Outpatient of the ASL of Biella (Piedmont Region, Italy).The best of both worlds - managing the cancer, saving the bone.A Novel Prothrombotic Pathway in Systemic Sclerosis Patients: Possible Role of Bisphosphonate-Activated γδ T Cells.Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells.Gamma delta T cells in non-immune patients during primary schistosomal infection.Pathogen-Specific Immune Fingerprints during Acute Infection: The Diagnostic Potential of Human γδ T-Cells.Osteoporosis - a current view of pharmacological prevention and treatmentActivated γδ T cells inhibit osteoclast differentiation and resorptive activity in vitro.The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women.Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody.Immune-mediated syndromes following intravenous bisphosphonate therapy.Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing.Immune cell profile of dental pulp tissue treated with zoledronic acid.Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drug.Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.γδ T cells predict outcome in zoledronate-treated breast cancer patients.Acute phase response after zoledronic acid is associated with long-term effects on white blood cells.Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation: the case of zoledronic acid-induced acute phase reaction.Current Advances in γδ T Cell-Based Tumor Immunotherapy.Immune cellular profile of bisphosphonate-related osteonecrosis of the jaw.CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells.Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial.Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood γδ T cells.
P2860
Q26859775-243BE2B5-3DBC-4F4E-9F68-2885EF247F2BQ33430116-CFEA8740-054C-48F9-BAEC-D73FA29FE723Q33781630-1586E473-1FAA-449E-8A6A-A9714B80493DQ33920055-35378C07-3E29-4D19-9367-76DB404511F0Q34148693-30FF8BFA-8E3A-4C30-A955-E8EFA9BECF0EQ34218508-4AB62AF9-D124-4B69-929C-109FBF79A608Q34454693-152AEA70-1381-4E1A-8820-0088917F393BQ34502154-3E4A7EF9-747C-429F-84CF-A5B0542E91E0Q36939677-7112991B-B201-4975-8BAE-B78D5F88C15CQ37310557-74AC3A9C-BD98-47BC-A6EF-9574E585F08CQ38611601-065BCFBF-7935-4DB5-B937-833939FEF004Q38728528-B8E65B37-C389-4E70-9577-400CBF6D3C88Q38752243-B6A2734D-44C7-40BA-9F74-D26DD330B43DQ38986536-99AC4BFB-FF90-4DD7-8ADF-DE91570C517CQ39098260-D06A82E5-46D9-42E1-94B7-B37D396A7C93Q39424272-F7EEB6B8-5DBD-4896-AB9C-56BD1B76DD7BQ40267794-E92CA981-3ED5-4C82-945C-068EA9A7005EQ42575266-3D6BCE43-FB91-464F-A20B-6E794B8533AFQ45731159-AA89D75C-570D-4425-A0E5-61EF96262D20Q46751057-789AA14C-AECC-4336-9EBE-9F54BC5E8F79Q47100174-2B8E54DE-0BF0-4C72-90B3-40F15CA5C50AQ48220380-D53CE245-2978-4125-8664-D6CB2B61DD19Q48331916-60BE6069-CBD5-42A5-B1BC-ADE8DE4D34F1Q50875567-44788919-D4A4-4BE2-BFA2-6DB8FDA81995Q54691443-606872D3-4897-4AC7-9D57-A4607BA1FB5C
P2860
Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Monocytes and γδ T cells contr ...... from a phase IV safety trial.
@en
Monocytes and γδ T cells contr ...... from a phase IV safety trial.
@nl
type
label
Monocytes and γδ T cells contr ...... from a phase IV safety trial.
@en
Monocytes and γδ T cells contr ...... from a phase IV safety trial.
@nl
prefLabel
Monocytes and γδ T cells contr ...... from a phase IV safety trial.
@en
Monocytes and γδ T cells contr ...... from a phase IV safety trial.
@nl
P2093
P2860
P50
P356
P1476
Monocytes and γδ T cells contr ...... s from a phase IV safety trial
@en
P2093
Jane Turton
Joanne L Welton
Michael D Stone
Salvador Martí
P2860
P304
P356
10.1002/JBMR.1797
P577
2013-03-01T00:00:00Z